We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Regulator Accuses Actavis, Concordia of Delaying Competition to Fix Prices
UK Regulator Accuses Actavis, Concordia of Delaying Competition to Fix Prices
The UK’s antitrust regulator alleges that Actavis and Concordia entered a pay-for-delay agreement to block the market entry of generic versions of hydrocortisone tablets and fix prices.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor